Hello to all our followers. After a long time treating pancreatic tumours, which keep oncology in check, we must share the great news of a treatment we are carrying out that is giving us the satisfaction of gaining ground against this fast-acting cancer.
So far we are managing to improve quality of life and, against the very pessimistic prognoses of official oncology, we can say that we are extending survival and also achieving remission and, in some cases now, the disappearance of the tumour.
This type of cancer is one of the most aggressive, one where many colleagues tend to throw in the towel and are defeated before the battle even begins.
Why it is so serious
Pancreatic cancer is not a certain death, but it is one of the most aggressive tumours with the worst prognosis in the world, with an overall five-year survival rate of around 8% to 13%.
- Late diagnosis: the pancreas is hidden behind other organs, so it usually shows no symptoms in its early stages. Between 80% and 85% of patients are diagnosed at advanced or metastatic stages.
- Low resectability rate: only around 15% to 20% of patients are candidates for surgery with curative intent at the time of diagnosis.
- Cases of survival: although the general statistics are low, there are patients who manage to overcome the disease or live long-term thanks to early detection, successful surgeries, combinations of chemotherapy or their participation in clinical trials. We approach these cases through multidisciplinary teams and advanced research that we have been carrying out for some time now; within these treatments we incorporate Adaptogen-Immunotherapy, which is completely free of side effects and entirely natural.
For any information you can contact us on WhatsApp and we will get in touch with you as soon as possible:
+34 648 822 591
Dr. Raimundo Torres Díaz